Unique aspects of the care of HIV-positive latino patients living in the United States

Current HIV/AIDS Reports

Volumn 7, Issue 3, 2010, Pages 107-116

  Garland, Joseph Metmowlee ^a   Andrade, Adriana S ^b   Page, Kathleen R ^b  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AIDS; Cultural competence; Hispanic; HIV; Immigrant health; Latino

Indexed keywords

ABACAVIR; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; EFAVIRENZ; LIPID; NELFINAVIR; STAVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; COCCIDIOIDOMYCOSIS; COUNSELING; CULTURAL FACTOR; DIABETES MELLITUS; DOMESTIC VIOLENCE; DYSLIPIDEMIA; EPIDEMIC; GENETIC POLYMORPHISM; HEALTH EDUCATION; HISPANIC; HISTOPLASMOSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN T CELL LEUKEMIA VIRUS 1; INFECTION RISK; INSULIN RESISTANCE; LEPROSY; LIPID BLOOD LEVEL; METABOLIC DISORDER; MIXED INFECTION; MYCOBACTERIUM LEPRAE; MYCOBACTERIUM TUBERCULOSIS; MYCOSIS; PARASITOSIS; PATIENT CARE; PATIENT COMPLIANCE; PERIPHERAL NEUROPATHY; PROSTITUTION; RACE DIFFERENCE; REVIEW; RHODOCOCCUS EQUI; SAFE SEX; SEXUAL BEHAVIOR; SIDE EFFECT; SOCIAL SUPPORT; SYPHILIS; TUBERCULOSIS; UNITED STATES; VIRUS INFECTION; ETHNOLOGY; HEALTH CARE DELIVERY; HIV INFECTIONS; MIGRATION; RISK FACTOR;

CULTURAL CHARACTERISTICS; DELIVERY OF HEALTH CARE; HISPANIC AMERICANS; HIV INFECTIONS; HUMANS; RISK FACTORS; TRANSIENTS AND MIGRANTS; UNITED STATES;

EID: 77955981154     PISSN: 15483568     EISSN: 15483576     Source Type: Journal    
DOI: 10.1007/s11904-010-0049-1     Document Type: Review

References (50)

1. Espinoza L, Hall IH, Selik RM, et al.: Characteristics of HIV infection among Hispanics, United States 2003-2006. J Acquir Immune Defic Syndr 2008, 49:94-101. This is a clear overview of the CDC data on Hispanics and AIDS.
2. Harrison KM, Song R, Zhang X: Life expectancy after HIV diagnosis based on national HIV surveillance data from 25 states, United States. J Acquir Immune Defic Syndr 2010, 53:124-130.
3. Pew Hispanic Center: Statistical portrait of Hispanics in the United States, 2008: Tabulations of 2008 American Community Survey. Available at http://pewhispanic.org/files/factsheets/hispanics2008/Table%206.pdf Accessed March 16, 2010.
4. Chen N, Erbelding E, Yeh HC, Page KR: Predictors of HIV testing among Latinos in Baltimore City. J Immigrant Minority Health 2009 Oct 15 (Epub ahead of print).
5. Lopez-Quintero C, Shtarkshall R, Neumark YD: Barriers to HIV testing among Hispanics in the United States: Analysis of the National Health Interview Survey, 2000. AIDS Patient Care STDS 2005, 19:672-683.
6. Moreno CL: The relationship between culture, gender, structural factors, abuse, trauma and HIV/AIDS for Latinas. Qual Health Res 2007, 17:340-353.
7. Muñoz-Laboy MA: Familism and sexual regulation among bisexual Latino men. Arch Sex Behav 2008, 37:773-782.
8. Gonzalez JS, Hendricksen ES, Collins EM, et al.: Latinos and HIV/AIDS: Examining factors related to disparity and identifying opportunities for psychosocial intervention research. AIDS Behav 2009, 13:582-602.
9. Fernández MI, Collazo JB, Hernández N, et al.: Predictors of HIV risk among Hispanic farm workers in South Florida; women are higher risk than men. AIDS Behav 2004, 8:165-174.
10. Parado EA, Flippen CA, McQuiston C: Use of commercial sex workers among Hispanic migrants in North Carolina: implications for the spread of HIV. Perspect Sex Reprod Health 2004, 36:150-156.
11. Kissinger P, Liddon N, Schmidt N, et al.: HIV/STI risk behaviors among Latino migrant workers in New Orleans post-Hurricane Katrina disaster. Sex Transm Dis 2008, 35:924-929.
12. Fisher TL, Burnet DL, Huang ES, et al: Cultural leverage: Interventions using culture to narrow racial disparities in health care. Med Care Res Rev 2007, 64:243S-282S.
13. Rajabiun S, Rumptz MH, Felizzola J, et al.: The impact of acculturation on Latinos' perceived barriers to HIV primary care.Ethn Dis 2008, 18:403-408.
14. Enriquez M, Farnan R, Cheng AL, et al: Impact of a bilingual/ bicultural care team on HIV-related health outcomes. J Assoc Nurses AIDS Care 2008, 19:295-301.
15. Rios-Ellis B, Frates J, D'Anna LH, et al.: Addressing the need for access to culturally and linguistically appropriate HIV/AIDS prevention for Latinos. J Immigr Minor Health 2008, 10:445-460.
16. Weidel JJ, Provencio-Vasquez E, Watson SD, et al.: Cultural considerations for intimate partner violence and HIV risk in Hispanics. J Assoc Nurses AIDS Care 2008, 19:247-251.
17. Panel on Antiretroviral Guidelines for Adults and Adolescents: Guidelines for the use of antiretroviral agents in HIV-1 infected adults and adolescents. Department of Health and Human Services. December 1, 2009; 1-161. Available at: http://www.aidsinfo.nih.gov/ContentFiles/AdultsandAdolescentGL.pdf. Accessed March 17, 2010. These are national guidelines for ARV use in HIV-1-infected patients.
18. Oh DL, Sarafian F, Silvestre A, et al.: Evaluation of adherence and factors affecting adherence to combination antiretroviral therapy among white, Hispanic and black men in the MACS cohort. J Acquir Immune Defic Syndr 2009, 52:290-293.
19. Sullivan PS, Campsmith ML, Nakamura GV, et al.: Patient and regimen characteristics associated with self-reported nonadherence to antiretroviral therapy. PLoS ONE 2007, 2:e552.
20. Silverberg MJ, Leyden W, Quesenberry CP, et al.: Race/ethnicity and risk of AIDS and death among HIV-infected patients with access to care. J Gen Intern Med 2009, 24:1065-1072.
21. Turner BJ, Fleishman JA: Effect of dysthymia on receipt of HAART by minority HIV-infected women J Gen Intern Med 2006, 21:1235-1241.
22. Rose CD, Myers J, Maiorana A, et al.: Predictors of stimulant and alcohol use among HIV-infected patients in care [abstract]. Poster presentation available at http://ari.ucsf.edu/programs/policy/dawson-rose-EPPEC.pdf. Accessed March 17, 2010.
23. Campo RE, Alvarez D, Santos G, et al.: Antiretroviral therapy considerations in Latino patients. AIDS Patient Care STDs 2005, 19:366-374.
24. Faruki H, Heine U, Brown T, et al.: HLA-B*5701 clinical testing: early experience in the United States. Pharmacogenet Genomics 2007, 17:857-860.
25. Hughes AR, Mosteller M, Bansal AT, et al.: Association of genetic variations in HLA-B region with hypersensitivity to abacavir in some, but not all, populations. Pharmacogenomics 2004, 5:203-211.
26. Haas DW: Will pharmacogenomic discoveries improve HIV therapeutics? Top HIV Med 2005, 13:90-95.
27. Mehlotra RK, Bockarie JM, Zimmerman PA: CYP2B6 983T>C polymorphism is prevalent in West Africa but absent in Papua New Guinea: implications for HIV/AIDS treatment. Br J Clin Pharmacol 2007, 64:391-395.
28. Tedaldi EM, Absalon J, Thomas AJ, et al.: Ethnicity, race and gender: Differences in serious adverse events among participants in an antiretroviral initiation trial: results of CPCRA 058 (FIRST Study). J Acquir Immune Defic Syndr 2008, 47:441-448.
29. Vega WA, Rodriguez MA, Gruskin E: Health disparities in the Latino population. Epidemiol Rev 2009, 31:99-112. This is a discussion of the health disparities that exist in the Latino community as compared to the general population, including a discussion of the "Hispanic health paradox."
30. Gibert CL, Shlay JC, Sharma S, et al.: Racial differences in changes of metabolic parameters and body composition in antiretroviral-therapy-naïve persons initiating antiretroviral therapy.J Acquir Immune Defic Syndr 2009, 50:44-53.
31. Foulkes AS, Wohl DA, Frank I, et al.: Associations among race/ ethnicity, ApoC-III genotypes, and lipids in HIV-1-infected individuals on antiretroviral therapy. PLoS Med 2006, 3:0337-0347.
32. Robinson-Papp J, Gonzalez-Duarte A, Simpson DM, et al.: The roles of ethnicity and antiretrovirals in HIV-associated polyneuropathy: a pilot study. J Acquir Immune Defic Syndr 2009, 51:569-573.
33. Centers for Disease Control and Prevention: Reported HIV status of tuberculosis patients-United States, 1993-2005. MMWR 2007, 56:1103-1106.
34. Rodwell TC, Barnes RFW, Moore M, et al.: HIV-tuberculosis coinfection in Southern California: evaluating disparities in disease burden. Am J Public Health 2010, 100(S1):S178-S185.
35. Deps PD, Lockwood DN: Leprosy occurring as immune reconstitution syndrome. Trans R Soc Trop Med Hyg 2008, 102:966-968.
36. Menezes VM, Sales AM, Illarramendi X, et al.: Leprosy reaction as a manifestation of immune reconstitution inflammatory syndrome: a case series of a Brazilian cohort. AIDS 2009, 23:641-643.
37. Rabagliati R, Morales A, Baudrand R, et al.: Neumonía cavitada por Rhodococcus equi en paciente inmunocomprometido no infectado por virus de inmunodeficiencia humana. Caso clínico y revisión. Rev Chil Infect 2005, 22:155-160.
38. Centers for Disease Control and Prevention: Primary and secondary syphilis-United States, 2002. MMWR 2003, 52:1117-1120.
39. Goldenberg SM, Cruz MG, Strathdee SA, et al.: Correlates of unprotected sex with female sex workers among male clients in Tijuana, Mexico. Sex Transm Dis 2010 Jan 14 (Epub ahead of print).
40. Gindi RM, Erbelding EJ, Page KR: Sexually transmitted infection prevalence and behavioral risk factors among Latino and non- Latino patients attending the Baltimore City STD clinics. Sex Transm Dis 2010, 37:191-196.
41. Paz-Bailey G, Teran S, Levine W, Markowitz LE: Syphilis outbreak among Hispanic immigrants in Decatur, Alabama: association with commercial sex. Sex Transm Dis 2004, 31:20-25.
42. Verdonck K, González E, Van Dooren S, et al.: Human Tlymphotropic virus 1: recent knowledge about an ancient infection. Lancet Infect Dis 2007, 7:266-281.
43. Casseb J, Posada-Vergara MP, Montanheiro P, et al.: T CD4 cells count among patients co-infected with human immunodeficiency virus type 1 (HIV-1) and human T-cell leukemia virus type 1 (HTLV-1): high prevalence of tropical spastic paraparesis/HTLV- 1-associated myelopathy (TSP/HAM). Rev Inst Med Trop S Paulo 2007, 49:231-233.
44. Collins JA, Hernández AV, Hidalgo JA, et al.: HTLV-1 infection is not associated with a higher risk of death in Peruvian HIVinfected patients. Rev Inst Med Trop S Paulo 2009, 51:197-201.
45. Alvar J, Aparicio P, Aseffa A, et al.: The relationship between leishmaniasis and AIDS: the second 10 years. Clin Microbiol Rev 2008, 21:334-359.
46. Sartori AM, Ibrahim KY, Nuñes Westphalen EV, et al.: Manifestations of Chagas disease (American trypanosomiasis) in patients with HIV/AIDS. Ann Trop Med Parasitol 2007, 101:31-50.
47. de Francesco Daher EF, de Sousa Barros FA, da Silva Júnior GB, et al.: Risk factors for death in acquired immunodeficiency syndrome-associated disseminated histoplasmosis. Am J Trop Med Hyg 2006, 74:600-603.
48. Andrade RA, Evans RT, Hamill RJ, et al.: Clinical evidence of interaction between itraconazole and nonnucleoside reverse transcriptase inhibitors in HIV-infected patients with disseminated histoplasmosis. Ann Pharmacother 2009, 43:908-913.
49. Masannat FY, Ampel NM: Coccidioidomycosis in patients with HIV-1 infection in the era of potent antiretroviral therapy. Clin Infect Dis 2010, 50:1-7.
50. Alvarez ME, Jakhmola P, Painter TM, et al.: Summary of Comments and Recommendations from the CDC Consultation on the HIV/AIDS epidemic and prevention in the Hispanic/Latino community. AIDS Educ Prev 2009, 21(Supp B):7-18. This is an overview of the CDC consultation on the HIV/AIDS epidemic in the Hispanic/Latino community, with goals outlined for future areas of investigation and interventions.